CinDome Pharma
OH - CincinnatiPharmaceutical
Focus: CinDome Pharma is a public pharmaceutical company headquartered in Cincinnati focused on oral, small molecule dopamine D2/D3 receptor antagonists for gastrointestinal disorders. The company operates in a narrow therapeutic niche with a single-asset pipeline in Phase 2 development.
Profile data last refreshed 2d ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
0
About CinDome Pharma
AI assessmentNot HiringNo open roles listed right now. Follow CinDome Pharma to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
4 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
CIN-102 Dose 15mg or 10mg
Diabetic GastroparesisClinical Trials (1)
NCT05832151A Study to Evaluate the Efficacy and Safety of CIN-102 (Deudomperidone) in Adults With Diabetic Gastroparesis
Phase 2Help build intelligence for CinDome Pharma
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.